NR4A1 and colorectal carcinoma: Compound K (CK) is a new ligand of Nur77, which promotes Nur77 to display resistance to Akt phosphorylation and further discouple from p63, leading to the Nur77-Akt feed-forward loop disruption and the regulation of CRC metastasis [136].